AI Verdict
REGN has stronger fundamentals based on our AI analysis.
MCK vs REGN Fundamental Comparison
| Metric | MCK | REGN |
|---|---|---|
| Revenue | $307.1B | $14.3B |
| Net Income | $3.1B | $4.5B |
| Net Margin | 1.0% | 31.4% |
| ROE | N/A | 14.4% |
| ROA | 3.7% | 11.1% |
| Current Ratio | 0.88x | 4.13x |
| Debt/Equity | N/A | 0.06x |
| EPS | $24.73 | $41.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MCK vs REGN: Frequently Asked Questions
Is MCK or REGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. MCK is rated BUY (70% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.
How does MCK compare to REGN fundamentally?
MCKESSON CORP has ROE of N/A vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 1.0% vs 31.4% respectively.
Which stock pays higher dividends, MCK or REGN?
MCK has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MCK or REGN for long term?
For long-term investing, consider that MCK has BUY rating with 70% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MCK vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MCK vs REGN, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.